Search
for
Sort by
Research 481–510 of 507
- Alopecia Areata Following the Use of Belimumab in a Patient with Systemic Lupus Erythematosus and Arthritis Who Responded Well to Baricitinib: A Case Report
- TACRINE
- Understanding, recognizing, and managing toxicities of targeted anticancer therapies
- Clinical and Immunological Phenotype of Patients With Primary Immunodeficiency Due to Damaging Mutations in NFKB2
- Off-Label Uses of Abrocitinib: Review of Emerging Therapeutic Applications beyond Atopic Dermatitis
- Construction of the coexpression network involved in the pathogenesis of thyroid eye disease via bioinformatics analysis
- Central Centrifugal Cicatricial Alopecia in the Adolescent Population: An Overview of Available Literature
- Refractory dermatomyositis–systemic lupus erythematosus overlap syndrome and response to tofacitinib
- Prevalence and treatment of Alopecia areata in Taif area, KSA
- Effects of Baicalin on Alopecia and the Associated Mechanism
- Off‐Label Use of Topical Ruxolitinib in Dermatology: A Systematic Literature Review and Current Perspectives
- Genome-Wide Association Study of Alopecia Areata in Taiwan: The Conflict Between Individuals and Hair Follicles
- In Vitro and Ex Vivo Hair Follicle Models to Explore Therapeutic Options for Hair Regeneration
- Insulin-like Growth Factor 1 (IGF-1) in Hair Regeneration: Mechanistic Pathways and Therapeutic Potential
- SLE classification criteria item relationships: implications on SLE as a disease entity
- The Role of Extracellular Vesicles in the Development and Treatment of Psoriasis: Narrative Review
- 50285 Oxytocin receptor is present in keratinocytes near touch and pain sensory neurons
- Anifrolumab treatment improves patient-reported quality of life and decreases disease activity and corticosteroid use in patients with systemic lupus erythematosus: A qualitative study in Denmark
- New spectrophotometric methods for the determination of Minoxidil
- Co-existence of Systemic Lupus Erythematosus and Celiac Disease: A Case Report
- Chemical Synthetic Disease Modifying Drugs (csDMARD) Used forRheumatoid Arthritis
- #6180 OXALATE NEPHROPATHY SECONDARY TO ENTERIC HYPEROXALURIA: A RARE CAUSE OF END STAGE RENAL FAILURE – A REPORT OF 2 CASES
- Recent Advances in Understanding of the Etiopathogenesis, Diagnosis, and Management of Hair Loss Diseases
- Circle Hairs in a Patient with Multiple Myeloma
- Immune-mediated Coombs negative intravascular haemolysis in systemic lupus erythematosus (SLE)
- Cutaneous Manifestations of Lupus Erythematosus
- ZALCITABINE
- Efficacy and safety of mycophenolate mofetil for lichen planopilaris
- Comparison of Systemic Mycophenolate Mofetil with Topical Clobetasol in Lichen Planopilaris: A Parallel-Group, Assessor- and Analyst-Blinded, Randomized Controlled Trial
- Mycophenolate mofetil as an alternative treatment for autoimmune hepatitis